Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
France's Senate backs ban on social media platforms for under-15s - 2Israel's haredi draft crisis: Court ruling and political stalemate reach breaking point
- 3Top 20 Compelling Business Books for Progress
- 4Mexico says a third of 130,000 missing people might be alive, fueling criticisms by families
- 5Canada Awards C$1.5 Billion Defense Contracts to L3Harris, Airbus
- Instructions to Really Oversee Unsold SUVs in the Auto Business
- The Response to Self-improvement: Embracing a Development Outlook
- Climate change is straining Alaska's Arctic. A new mining road may push the region past the brink
- Instructions to Guarantee Kids Foster Solid Dental Propensities
- Dolly Parton misses Dollywood event due to 'a few health challenges' after skipping honorary Oscars
- Home Mechanization Frameworks for Brilliant Residing
- Novo Nordisk cuts Wegovy price in South Africa for a second time
- Nikki Glaser has been testing out Golden Globes jokes. There's one nobody wants to hear
- Earth's newfound 'episodic-squishy lid' may guide our search for habitable worlds
